Chemoinformaics analysis of (10E,12E)-9-HYDROPEROXYOCTADECA-10,12-DIENOIC ACID
| Molecular Weight | 312.45 | nRot | 15 |
| Heavy Atom Molecular Weight | 280.194 | nRig | 20 |
| Exact Molecular Weight | 312.23 | nRing | 0 |
| Solubility: LogS | -3.523 | nHRing | 0 |
| Solubility: LogP | 2.809 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 54.6054 |
| nHD | 2 | BPOL | 32.9706 |
| QED | 0.428 |
| Synth | 6.117 |
| Natural Product Likeliness | 2.894 |
| NR-PPAR-gamma | 0.592 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.031 |
| Pgp-sub | 0 |
| HIA | 0.017 |
| CACO-2 | -4.659 |
| MDCK | 0.0000269 |
| BBB | 0.059 |
| PPB | 0.705765 |
| VDSS | 2.146 |
| FU | 0.121962 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.505 |
| CYP2c19-inh | 0.403 |
| CYP2c19-sub | 0.78 |
| CYP2c9-inh | 0.689 |
| CYP2c9-sub | 0.035 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.492 |
| CYP3a4-sub | 0.23 |
| CL | 11.897 |
| T12 | 0.091 |
| hERG | 0.004 |
| Ames | 0.191 |
| ROA | 0.924 |
| SkinSen | 0.594 |
| Carcinogencity | 0.283 |
| EI | 0.074 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.837 |
| Antiviral | Yes |
| Prediction | 0.596724 |